Bernard Escudier
Papers
4
Total Citations
3,050
H-Index
3
About
Bernard Escudier is a world-renowned oncologist whose work has fundamentally shaped the management of renal cell carcinoma (RCC). His primary research focus lies in the development of targeted therapies and the establishment of evidence-based clinical guidelines for kidney cancer. As the lead author of the ESMO Clinical Practice Guidelines for RCC, his contributions have become the global standard for diagnosis, treatment, and follow-up, with his 2014 edition alone amassing over 2,200 citations. These guidelines have directly influenced clinical decision-making worldwide, ensuring patients receive optimal, standardized care. Beyond guideline development, Escudier has been a pioneer in investigating novel therapeutic strategies, such as the use of axitinib to downstage tumors and enable nephron-sparing surgery, as seen in the AXIPAN trial. His work bridges the gap between cutting-edge research and practical patient care, making him a pivotal figure in oncology. With a citation impact exceeding 3,000 for his most influential works, Escudier’s legacy is defined by his relentless pursuit of improving outcomes for patients with renal cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4